RAP - The Next Phase, page-1283

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 1283 Last

Share
Profile

Follow
Siva108

8,801 Posts.

582

28/06/16

04:04

Post #: 18136671
Share

Originally posted by ClownTrader ↑

Spot on,
The reason why more diseases haven't been reported yet is purely because there hasn't yet been enough available cases to diagnose. That will come.

The price sensitivity of an 'US hospital ann' lies in the fact that the size of the US hospital(s) will give the market a reasonable gauge of the time it will take to get to the stage where we can submit the application(s) to the FDA. If we land a few hospitals that are well known whoppers, the price will climb FAST.

The faster we collect and submit results to the FDA, the faster we get to the FDA approval and the faster we become a T/O target. The bottleneck at the moment is the rate of sampling. The US hospitals effectively will turn the sampling rate tap from a dribble to a gush, and I expect the share price rise to increase accordingly.

Expect additional respiratory diseases/conditions to be added to the mix. These will form additional, seperate FDA submissions that will in time increase the functionality and scope of the ResApp.

Lastly, I don't expect the escrowed shares to be an obstacle that might cause a retrace. Considering who they are and how they relate to this stock, it is highly unlikely Uniquest will offload their escrowed shares. Plus things are only just starting to get exciting so I doubt they would be that foolish.

I may be wrong, but I believe that the strength of today's trading makes it abundantly clear that there is more than one big fish starting to gobble up shares. I said a week back that we would see some big swings. It is clear that tree shakes won't hold the price down long for too long and I think it will be a costly mistake for someone to try it again; it works best on small volume and thin buy sides, but if there are competing big funds it is suicide. So following that sort of thing, it is my experience that soon slow, steady bites will become the order of the day. A gradual climb though July suits me fine

Regards CT

Expand

Hi CT you mentioned the escrow shares go to Uniquest. I have seen many posters saying they don't believe these shares are going into "safe hands" but it seems to me that Uniquest are as safe a bet as any as they have a vested interest in RAP so why would they offload all of the shares immediately onto the market? Knowing the future of RAP that would seem silly...

RAP Price at posting: 36.5¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

As Nvidia cools, we're looking to Aussie AI

CBA breaks trading record on strong day for Aussie financials

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

There are more pages in this discussion • 951 more messages in this thread...

First 1283 Last

Add RAP (ASX) to my watchlist

RAP - The Next Phase, page-1283

Top Stories

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

As Nvidia cools, we're looking to Aussie AI

CBA breaks trading record on strong day for Aussie financials

Shekel Brainweigh investor presentation webinar – the future of retail automation

Featured News